K. Aonuma

MAIR‐II deficiency ameliorates cardiac remodelling post‐myocardial infarction by suppressing TLR9‐mediated macrophage activation

K. Aonuma, M. Ieda, Saori Yonebayashi, 2020, Journal of cellular and molecular medicine.

Clean manuscript number: CS-2021-0405 Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats

A. Sato, K. Aonuma, A. Nogami, 2021 .

Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.

K. Aonuma, M. Ieda, K. Tajiri, 2022, Life sciences.

Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice

K. Aonuma, Honglan Huang, M. Ieda, 2021, International journal of molecular sciences.

Linear Biazulene Isomers: Effects of Molecular and Packing Structure on Optoelectronic and Charge-Transport Properties

Y. Yamaguchi, D. Kumaki, S. Tokito, 2020 .

Effects of Isorhamnetin in Human Amniotic Epithelial Stem Cells in vitro and Its Cardioprotective Effects in vivo

F. Ferdousi, H. Isoda, Kenichi Tominaga, 2020, Frontiers in Cell and Developmental Biology.

Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.

K. Aonuma, H. Isoda, A. Nogami, 2022, Clinical science.

Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy

K. Aonuma, M. Ieda, K. Tajiri, 2023, Frontiers in Cardiovascular Medicine.

An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.

K. Aonuma, C. Miyoshi, Hiromasa Funato, 2024, Proceedings of the National Academy of Sciences of the United States of America.

Impact of isorhamnetin for suppression of electrical and structural remodeling via CaMKII-RyR2 and TRPC-mediated MAPK pathways in atrial fibrillation

K. Aonuma, H. Isoda, A. Nogami, 2022 .